Preparation of vaginal composite dressing and application thereof in treating gynecological diseases
A vaginal, uniform mixing technology, applied in the field of medical device manufacturing, to achieve the effect of improving vulva redness and inflammation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] A preparation method of a vaginal composite dressing, the specific preparation method comprising the following steps:
[0031] (1) Screening of raw and auxiliary materials: sieve lactose monohydrate, magnesium stearate, micronized silica gel, and povidone K30 respectively;
[0032] (2) Feeding: Feed according to the formula requirements according to the weight ratio;
[0033] (3) Mixing: The raw materials after feeding are mixed evenly in the stirring container;
[0034] (4) Granulation: The uniformly mixed powder is granulated by a granulator;
[0035] (5) Drying: the granules are dried with a dryer;
[0036] (6) Tablet compression: the dried granules are compressed with a tablet machine.
[0037] Further, in the step (1), the sieve used for sieving lactose monohydrate, magnesium stearate, micronized silica gel, and povidone K30 is 100 mesh;
[0038] Further, the parts by weight of each component fed in the step (2) are: 13 parts of lactose monohydrate, 83 parts of...
Embodiment 2
[0043] All the other are with embodiment 1,
[0044] Further, in the step (1), the sieve used for sieving lactose monohydrate, magnesium stearate, micronized silica gel, and povidone K30 is 120 mesh;
[0045] Further, the parts by weight of each component fed in the step (2) are: 11 parts of lactose monohydrate, 85 parts of magnesium stearate, 4 parts of micropowdered silica gel, and 4 parts of povidone K30;
[0046] Further, the mixing time in the step (3) is 40 min;
[0047] Further, the particles in the step (5) are dried to a moisture content of 4.0%;
[0048] Further, the weight of a single tablet after tableting in the step (6) is 0.9 g.
Embodiment 3
[0050] All the other are with embodiment 1,
[0051] Further, in the step (1), the sieve used for sieving lactose monohydrate, magnesium stearate, micronized silica gel, and povidone K30 is 80 mesh;
[0052] Further, the parts by weight of each component fed in the step (2) are: 12 parts of lactose monohydrate, 85 parts of magnesium stearate, 5 parts of micropowdered silica gel, and 2 parts of povidone K30;
[0053] Further, the mixing time in the step (3) is 50 min;
[0054] Further, the particles in the step (5) are dried to a moisture content of 3.0%;
[0055] Further, the weight of a single tablet after tableting in the step (6) is 0.6 g.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com